Mean weight and waist circumference were 209.5 ± 45.6 lbs and 43.1 ± 18.8 inches, respectively.
However the mean weight, BMI, waist and hip circumferences were significantly lower in the patients with DR (Table 1).
During the past 12 years the mean weight, height, waist, and hip measurements increased by 8 kg, 1 cm, 7 cm, and 3 cm in men; and by 6 kg, 1 cm, 6 cm, and 7 cm in women, respectively.
Secondary outcomes were self-efficacy, locus of control, mean blood pressure, mean weight loss, mean waist circumference, mean HbA1c and mean total cholesterol levels and quality of life.
Mean baseline body weight, waist circumference, and BMI was 100 kg, 109 cm, and 36 kg/m, respectively.
Secondary outcomes were improved diabetes-specific self-efficacy, locus of control, mean blood pressure, mean weight loss, mean waist circumference, mean HbA1c and mean total cholesterol levels, and quality of life.
The mean weight, height, and waist circumference of the male students were significantly higher than those of the females (p < 0.05).
There were progressive statistically significant reductions in mean weight, fat mass, waist and BMI throughout the duration of monitoring (p < 0.001).
Mean weight, BMI, and waist circumference at baseline was 215.3 ± 44.4 lbs, 36.9 ± 9.2 kg/m, and 44.2 ± 12.4 inches, respectively (Table 1).
At randomization the mean age was 44 years, 67% of subjects were white, 19% were black, 83.5% were female, and the mean weight, BMI, and waist circumference was 100 kg, 36 kg/m, and 109 cm, respectively.
